This white paper will explore some of the critical challenges to the pharmaceutical industry with a focus on messenger ribonucleic acid3 (mRNA) vaccines, given that this novel technology is poised to be applied in the treatment of a range of diseases following a successful first deployment in Pfizer-BioNTech’s COVID-19 vaccine. Blackbird.AI’s tech-driven approach provides a deeper insight into the key conversations, drivers and impact around this issue by bringing to bear our unique capabilities and expertise in the field of digital information integrity.